SenesTech, Inc. is facing a significant challenge as it received a notification from Nasdaq regarding its stock price. The company, which specializes in rodent population management, has seen its common stock close below $1.00 per share for 30 consecutive business days. This puts it at risk of being delisted from the Nasdaq Capital Market.
On October 20, 2026, SenesTech received a letter from Nasdaq's listing qualifications staff informing them of this situation. According to Nasdaq Listing Rule 5550(a)(2), companies must maintain a minimum bid price of $1.00 to remain listed. The notification does not immediately affect the listing, as SenesTech will continue to trade under the symbol “SNES” while it works to regain compliance.
SenesTech has until April 19, 2027, to bring its stock price back above the $1.00 threshold for at least 10 consecutive business days. If the company fails to do so, it may be eligible for an additional 180-day compliance period, provided it meets other listing requirements. However, if Nasdaq determines that SenesTech cannot cure the deficiency, the company may face delisting.
“We take the Nasdaq notification seriously, and we intend to use the compliance period to keep demonstrating the progress we are making in the business,” said Michael Edell, President and Chief Executive Officer of SenesTech. The company recently reported a record third-quarter revenue of approximately $1.1 million, marking a 40% increase from the previous quarter and a 55% increase year-over-year.
SenesTech's commitment to financial management is evident as it evaluates its financing requirements and considers options to regain compliance with Nasdaq's listing rules. The company aims to balance maintaining adequate liquidity while minimizing dilution for existing shareholders.
Founded in Delaware and headquartered in Surprise, Arizona, SenesTech is a leader in agricultural chemicals, specifically targeting rodent population control through its innovative products. The company’s Evolve® and ContraPest® solutions aim to provide sustainable management of rodent populations, which is crucial for both consumer and professional markets.
The situation at SenesTech reflects broader challenges in the agricultural chemicals industry, where companies must navigate fluctuating market conditions and regulatory requirements. Competitors in this space may find opportunities to strengthen their market positions as SenesTech addresses its compliance issues.
As of now, the company is actively monitoring its stock price and will explore various strategies to ensure it meets Nasdaq's requirements. The outcome of this situation remains uncertain, but SenesTech's proactive approach may play a crucial role in its future.
Details were not available in the SEC filing regarding the next steps beyond the compliance period. The company is expected to continue its efforts to stabilize its stock price and maintain its listing on the Nasdaq.